For the development of our compounds, we had the collaboration of the following universities:
Our partners are prestigious firms in patents, lawyers, CROs and assessments.
New family of molecules with oral therapeutic potential in NAFLD, NASH, obesity, hypertension, dyslipidemia and type 2 diabetes